Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 1

3(60.0%)

Phase 4

1(20.0%)

Phase 2

1(20.0%)

5Total

Phase 1(3)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT02994602Phase 1Completed

Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males

Role: lead

NCT01586000Phase 2Completed

A Dose-finding Study to Evaluate the Effect of a Contraceptive Vaginal Ring, Releasing Nestorone® and Estradiol, on Cycle Control, Ovulation Inhibition, and Pharmacokinetics in Normal Cycling Women

Role: lead

NCT03537768Phase 4Terminated

Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kg

Role: lead

NCT02927210Phase 1Completed

Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015)

Role: lead

NCT02432261Phase 1Completed

Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in Men

Role: lead

All 5 trials loaded